#Japan #Tokyo #regenerative medicine #CPC Corporation #JSOA2025

CPC Corporation and JSOA2025: A Luncheon Seminar on Regenerative Medicine

CPC Corporation, headquartered in Chiyoda, Tokyo, is a recognized leader in regenerative medicine services, offering comprehensive support from the introduction to the management of regenerative medical facilities. Recently, the company has expanded its operations to include cell culture processing, operating a facility approved under Japan's Regenerative Medicine Safety Assurance Law. This innovative approach not only enhances patient care but also ensures the highest safety standards in regenerative medicine practices.

In a significant stride towards knowledge sharing in this field, CPC Corporation is thrilled to announce its collaboration with the Japanese Society of Sports Orthopedic Surgery (JSOA) to host a luncheon seminar on September 13, 2025, during the JSOA2025 event. The seminar aims to bring together leading experts and practitioners to discuss the latest advancements in regenerative medicine and its applications in sports orthopedics.

Overview of the Event

• - Date: September 13, 2025
• - Time: 12:00 PM – 1:00 PM
• - Venue: The Prince Park Tower Tokyo, Room Shakunage (seating capacity: approximately 180)

The seminar will be chaired by Dr. Kengo Harato, an Associate Professor at the Keio University Sports Medicine Research Center. Dr. Harato is a prominent figure in the field of sports medicine and has been actively involved in research that bridges sports science and medical practice. The event will feature presentations from distinguished speakers including Dr. Ryota Yamagami, a Special Lecturer in Orthopedic Surgery at the Graduate School of Medicine, The University of Tokyo, and Dr. Taro Kasai, also a Special Lecturer in the same department. Their contributions will provide deeper insights into the revolutionary applications of regenerative medicine in enhancing athletic performance and recovery.

Attendees will not only gain valuable knowledge from these experts but also have the opportunity to network with professionals in the health and sports medicine sectors. This event underscores the importance of collaboration between academic institutions and corporate entities in driving forward the field of regenerative medicine.

Participants interested in attending the seminar can find more information and register through the official JSOA2025 website. This is a unique chance for medical professionals, researchers, and sports practitioners to engage in discussions that could shape the future of sports orthopedics.

About CPC Corporation

Founded by Keita Inoue, CPC Corporation is committed to advancing regenerative medicine through innovative practices and collaboration. Their state-of-the-art cell culture processing facility is a testament to their dedication to providing high-quality support for medical institutions. Located in the heart of Tokyo, CPC continues to make significant contributions to the health sector with a focus on patient safety and effective treatment solutions. For more details, visit their corporate site or their brand website for cellular services at TOPS Cells.

In conclusion, the forthcoming luncheon seminar at JSOA2025 represents an important convergence of knowledge and practice in regenerative medicine. With thought leaders gathering to share insights, attendees will walk away with not just information but inspiration to further their endeavors in sports medicine and regenerative therapies.